Suppr超能文献

辛伐他汀通过修饰小分子 GTP 酶激活纺锤体组装检查点,导致异常细胞分裂。

Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases.

机构信息

Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan.

Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan.

出版信息

Cell Signal. 2024 Jul;119:111172. doi: 10.1016/j.cellsig.2024.111172. Epub 2024 Apr 9.

Abstract

Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, which is a rate-limiting enzyme of the cholesterol synthesis pathway. It has been used clinically as a lipid-lowering agent to reduce low-density lipoprotein (LDL) cholesterol levels. In addition, antitumor activity has been demonstrated. Although simvastatin attenuates the prenylation of small GTPases, its effects on cell division in which small GTPases play an important role, have not been examined as a mechanism underlying its cytostatic effects. In this study, we determined its effect on cell division. Cell cycle synchronization experiments revealed a delay in mitotic progression in simvastatin-treated cells at concentrations lower than the IC. Time-lapse imaging analysis indicated that the duration of mitosis, especially from mitotic entry to anaphase onset, was prolonged. In addition, simvastatin increased the number of cells exhibiting misoriented anaphase/telophase and bleb formation. Inhibition of the spindle assembly checkpoint (SAC) kinase Mps1 canceled the mitotic delay. Additionally, the number of cells exhibiting kinetochore localization of BubR1, an essential component of SAC, was increased, suggesting an involvement of SAC in the mitotic delay. Enhancement of F-actin formation and cell rounding at mitotic entry indicates that cortical actin dynamics were affected by simvastatin. The cholesterol removal agent methyl-β-cyclodextrin (MβCD) accelerated mitotic progression differently from simvastatin, suggesting that cholesterol loss from the plasma membrane is not involved in the mitotic delay. Of note, the small GTPase RhoA, which is a critical factor for cortical actin dynamics, exhibited upregulated expression. In addition, Rap1 was likely not geranylgeranylated. Our results demonstrate that simvastatin affects actin dynamics by modifying small GTPases, thereby activating the spindle assembly checkpoint and causing abnormal cell division.

摘要

辛伐他汀是 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶的抑制剂,该酶是胆固醇合成途径中的限速酶。它已被临床用作降低血脂的药物,以降低低密度脂蛋白(LDL)胆固醇水平。此外,还表现出抗肿瘤活性。尽管辛伐他汀可减弱小 GTPase 的 prenylation,但尚未研究其作为细胞生长抑制作用的机制,即其对在其中小 GTPase 发挥重要作用的细胞分裂的影响。在这项研究中,我们确定了其对细胞分裂的影响。细胞周期同步化实验表明,在低于 IC 的浓度下,辛伐他汀处理的细胞有丝分裂进程延迟。延时成像分析表明,有丝分裂持续时间,特别是从有丝分裂进入到后期开始,延长了。此外,辛伐他汀增加了表现出定向错误的后期/末期和泡形成的细胞数量。纺锤体组装检查点(SAC)激酶 Mps1 的抑制取消了有丝分裂延迟。此外,显示着丝粒定位的细胞数量增加,着丝粒定位是 SAC 的一个必需成分,这表明 SAC 参与了有丝分裂的延迟。在有丝分裂进入时增强 F-肌动蛋白形成和细胞圆化表明皮质肌动蛋白动力学受辛伐他汀影响。胆固醇去除剂甲基-β-环糊精(MβCD)的促有丝分裂进程与辛伐他汀不同,表明质膜中胆固醇的丢失不参与有丝分裂延迟。值得注意的是,作为皮质肌动蛋白动力学的关键因素的小 GTPase RhoA 表达上调。此外,Rap1 不太可能 geranylgeranylated。我们的结果表明,辛伐他汀通过修饰小 GTPase 来影响肌动蛋白动力学,从而激活纺锤体组装检查点并导致异常细胞分裂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验